|Articles|September 15, 2015
Gregory J. Riely on the Identification and Treatment of MET Exon 14 Skipping Mutations
Author(s)Gregory J. Riely
Gregory J. Riely, associate attending physician, Memorial Sloan Kettering Cancer Center, discusses identifying and treating patients with MET exon 14 skipping mutations in lung cancer.
Advertisement
Gregory J. Riely, associate attending physician, Memorial Sloan Kettering Cancer Center, discusses identifying and treating patients with MET exon 14 skipping mutations in lung cancer.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Hyrnuo in Some with Locally Advanced/Metastatic NSCLC
2
FDA Approves Imdelltra for Extensive-Stage Small Cell Lung Cancer
3
FDA Accepts NDA for Zidesamtinib in Previously Treated ROS1+ NSCLC
4
FDA Grants Fast Track Status to New Gastric Cancer Treatment
5
